Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 3 Completed 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 704 Carcinoma, Non-Small-Cell Lung 470 Prostatic Neoplasms 420 Neoplasms 380 Multiple Myeloma 264 Colorectal Neoplasms 261 Lung Neoplasms 247 Neoplasm Metastasis 229 Melanoma 215 Ovarian Neoplasms 191 Leukemia, Myeloid, Acute 189 Pancreatic Neoplasms 182 Squamous Cell Carcinoma of Head and Neck 163 Recurrence 147 Carcinoma, Renal Cell 145 Lymphoma 142 Glioblastoma 138 Lymphoma, Non-Hodgkin 135 Stomach Neoplasms 128 Triple Negative Breast Neoplasms 127 Brain Neoplasms 124 Carcinoma, Hepatocellular 123 Leukemia, Lymphocytic, Chronic, B-Cell 122 Uterine Cervical Neoplasms 117 Head and Neck Neoplasms 117 Precursor Cell Lymphoblastic Leukemia-Lymphoma 115 Urinary Bladder Neoplasms 113 Lymphoma, Large B-Cell, Diffuse 105 Sarcoma 102 Lymphoma, Follicular 100

Interventions

tremelimumab 1 olaparib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Immunotherapy × Clear all

NCT04169841 2024-02-13

GUIDE2REPAIR

Centre Georges Francois Leclerc

Phase 2 Active not recruiting

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡